OBJECTIVE: •To determine the role of global histone methylation as a prognostic parameter in patients with bladder cancer. PATIENTS AND METHODS: •We used a tissue microarray with samples from patients with non-muscle-invasive bladder cancer (NMIBC; n= 161), muscle-invasive bladder cancer (MIBC, n= 127), normal urothelium (NU; n= 31) and bladder cancer metastases (METS; n= 31) to determine global histone methylation (me) levels at histone H3 lysine 4 (H3K4) and H4K20. RESULTS: •Global histone modification levels (H3K4me1, H3K4me3, H4K20me1, H4K20me2, and H4K20me3) were lower in bladder cancer samples than in NU tissue •Global levels of H3K4me1, H4K20me1, H4K20me2 and H4K20me3 were decreasing from NU over NMIBC and MIBC to METS. •H4K20me1 levels were increased in patients with NMIBC with advanced pTstage and less differentiated bladder cancer. •In patients with MIBC, pTstage was negatively correlated with H3K4me1, H4K20me1 and H4K20me2 levels. •H4K20me3 levels were significantly correlated in a univariate and multivariate model with bladder cancer-specific mortality after radical cystectomy in patients with MIBC. CONCLUSION: •Global histone methylation levels may help to identify patients with bladder cancer with poor prognosis after radical cystectomy.
OBJECTIVE: •To determine the role of global histone methylation as a prognostic parameter in patients with bladder cancer. PATIENTS AND METHODS: •We used a tissue microarray with samples from patients with non-muscle-invasive bladder cancer (NMIBC; n= 161), muscle-invasive bladder cancer (MIBC, n= 127), normal urothelium (NU; n= 31) and bladder cancer metastases (METS; n= 31) to determine global histone methylation (me) levels at histone H3 lysine 4 (H3K4) and H4K20. RESULTS: •Global histone modification levels (H3K4me1, H3K4me3, H4K20me1, H4K20me2, and H4K20me3) were lower in bladder cancer samples than in NU tissue •Global levels of H3K4me1, H4K20me1, H4K20me2 and H4K20me3 were decreasing from NU over NMIBC and MIBC to METS. •H4K20me1 levels were increased in patients with NMIBC with advanced pTstage and less differentiated bladder cancer. •In patients with MIBC, pTstage was negatively correlated with H3K4me1, H4K20me1 and H4K20me2 levels. •H4K20me3 levels were significantly correlated in a univariate and multivariate model with bladder cancer-specific mortality after radical cystectomy in patients with MIBC. CONCLUSION: •Global histone methylation levels may help to identify patients with bladder cancer with poor prognosis after radical cystectomy.
Authors: Yu Chen; Michael E Hoover; Xibei Dang; Alan A Shomo; Xiaoyan Guan; Alan G Marshall; Michael A Freitas; Nicolas L Young Journal: Mol Cell Proteomics Date: 2015-07-24 Impact factor: 5.911
Authors: Xuejiao Tian; Saiyang Zhang; Hong-Min Liu; Yan-Bing Zhang; Christopher A Blair; Dan Mercola; Paolo Sassone-Corsi; Xiaolin Zi Journal: Curr Cancer Drug Targets Date: 2013-06 Impact factor: 3.428
Authors: Kelly H Telu; Besma Abbaoui; Jennifer M Thomas-Ahner; Debra L Zynger; Steven K Clinton; Michael A Freitas; Amir Mortazavi Journal: J Proteome Res Date: 2013-06-17 Impact factor: 4.466
Authors: Matthias Hahn; Silvia Dambacher; Stanimir Dulev; Anastasia Yurievna Kuznetsova; Simon Eck; Stefan Wörz; Dennis Sadic; Maike Schulte; Jan-Philipp Mallm; Andreas Maiser; Pierre Debs; Harald von Melchner; Heinrich Leonhardt; Lothar Schermelleh; Karl Rohr; Karsten Rippe; Zuzana Storchova; Gunnar Schotta Journal: Genes Dev Date: 2013-04-18 Impact factor: 11.361
Authors: Turang E Behbahani; Philip Kahl; Johannes von der Gathen; Lukas C Heukamp; Claudia Baumann; Ines Gütgemann; Bernhard Walter; Ferdinand Hofstädter; Patrick J Bastian; Alexander von Ruecker; Stefan C Müller; Sebastian Rogenhofer; Jörg Ellinger Journal: BMC Urol Date: 2012-03-13 Impact factor: 2.264
Authors: Adam G Evertts; Amity L Manning; Xin Wang; Nicholas J Dyson; Benjamin A Garcia; Hilary A Coller Journal: Mol Biol Cell Date: 2013-08-07 Impact factor: 4.138